Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes-Reference-Cited by-同舟云学术

Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes

Published:2014-04-09 Issue:2 Volume:145 Page:281-293
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

McNamara Keely M.,Yoda Tomomi,Nurani Alif Meem,Shibahara Yukiko,Miki Yasuhiro,Wang Lin,Nakamura Yasuhiro,Suzuki Koyu,Yang Yang,Abe Eriko,Hirakawa Hisashi,Suzuki Takashi,Nemoto Noriko,Miyashita Minoru,Tamaki Kentaro,Ishida Takanori,Brown Kristy A.,Ohuchi Noriaki,Sasano Hironobu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2942-6.pdf

Reference40 articles.

1. Bosch A, Eroles P, Zaragoza R, Vina JR, Lluch A (2010) Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 36(3):206–215. doi: 10.1016/j.ctrv.2009.12.002

2. Hickey TE, Robinson JL, Carroll JS, Tilley WD (2012) Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26(8):1252–1267. doi: 10.1210/me.2012-1107

3. McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H (2013) Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol 133:66–76. doi: 10.1016/j.jsbmb.2012.08.007

4. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R (2005) Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24(29):4660–4671. doi: 10.1038/sj.onc.1208561

5. Ormandy CJ, Clarke CL, Kelly PA, Sutherland RL (1992) Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells. Int J Cancer 50(5):777–782

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines;International Journal of Molecular Sciences;2024-07-19

2. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08

3. Preclinical support for tumor protein D52 as a cancer vaccine antigen;Human Vaccines & Immunotherapeutics;2023-10-30

4. Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers;npj Breast Cancer;2022-04-20

5. Impact of Androgen Receptor Expression and the AR:ER Ratio on the Survival Outcomes in the Diverse Subgroups of Vietnamese Breast Cancer: A Single Institutional Retrospective Cohort Analysis;Technology in Cancer Research & Treatment;2022-01